Published in Am J Respir Crit Care Med on March 01, 1994
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax (1996) 2.29
Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ (1996) 2.20
Accuracy of recording of deaths from asthma in the UK: the false negative rate. Thorax (1996) 1.86
Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A (2004) 1.85
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax (2002) 1.81
Major reduction in asthma morbidity and continued reduction in asthma mortality in New Zealand: what lessons have been learned? Thorax (1995) 1.50
Cardiovascular side effects of inhaled salbutamol in hypoxic asthmatic patients. Thorax (2001) 1.41
Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ (2001) 1.32
Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther (2007) 1.30
Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24
Cardiovascular morbidity and the use of inhaled bronchodilators. Int J Chron Obstruct Pulmon Dis (2008) 1.17
Respiratory medications and risk of asthma death. Thorax (2002) 1.06
Relationship between recent short-acting beta-agonist use and subsequent asthma exacerbations. Ann Allergy Asthma Immunol (2008) 1.04
Monitoring community pharmacist's quality of care: a feasibility study of using pharmacy claims data to assess performance. BMC Health Serv Res (2011) 0.91
Management of asthma in adults: current therapy and future directions. Postgrad Med J (2003) 0.88
The national review of asthma deaths: what did we learn and what needs to change? Breathe (Sheff) (2015) 0.87
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan. CMAJ (1995) 0.87
Asthma and the beta agonist debate. Thorax (1995) 0.85
Prevalence of asthma among schoolchildren in Patras, Greece: three surveys over 20 years. Thorax (2001) 0.84
Lack of association between ipratropium bromide and mortality in elderly patients with chronic obstructive airway disease. Thorax (2000) 0.82
Status Report--Retracing the history of the early development of national chronic disease surveillance in Canada and the major role of the Laboratory Centre for Disease Control (LCDC) from 1972 to 2000. Health Promot Chronic Dis Prev Can (2015) 0.80
Use of mobile devices and the internet for multimedia informed consent delivery and data entry in a pediatric asthma trial: Study design and rationale. Contemp Clin Trials (2015) 0.80
Pharmacogenetics of the beta 2-adrenergic receptor gene. Immunol Allergy Clin North Am (2007) 0.79
Peroxidative metabolism of beta2-agonists salbutamol and fenoterol and their analogues. Chem Res Toxicol (2009) 0.77
Integrin and GPCR Crosstalk in the Regulation of ASM Contraction Signaling in Asthma. J Allergy (Cairo) (2012) 0.76
Airway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activity. J Pharmacol Exp Ther (2010) 0.76
Pediatric asthma mortality and hospitalization trends across Asia pacific: relationship with asthma drug utilization patterns. World Allergy Organ J (2009) 0.75
Oral vs inhaled asthma therapy. Pros, cons and combinations. Drugs (1996) 0.75
Asthma in adults. BMJ Clin Evid (2011) 0.75
Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial. NPJ Prim Care Respir Med (2017) 0.75
Asthma-related deaths. Multidiscip Respir Med (2016) 0.75
The Danish National Database for Asthma: establishing clinical quality indicators. Eur Clin Respir J (2016) 0.75
Asthma in adults. BMJ Clin Evid (2010) 0.75
The effects of acute and chronic nadolol treatment on β2AR signaling in HEK293 cells. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.75
Rise and fall of asthma-related mortality in Italy and sales of beta2-agonists, 1980-1994. Eur J Epidemiol (2000) 0.75
Using administrative healthcare data to recruit study subjects: experience with 'camouflaged sampling'. Eur J Epidemiol (2004) 0.75
Prognostic nomogram for inpatients with asthma exacerbation. BMC Pulm Med (2017) 0.75
Risks associated with managing asthma without a preventer: urgent healthcare, poor asthma control and over-the-counter reliever use in a cross-sectional population survey. BMJ Open (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med (2001) 27.83
Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med (2000) 19.56
The Burlington randomized trial of the nurse practitioner. N Engl J Med (1974) 17.02
Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med (1990) 16.54
A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med (1994) 11.54
Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA (1994) 10.46
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group. CMAJ (1999) 7.05
Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. J Chronic Dis (1981) 7.00
Global burden of COPD: systematic review and meta-analysis. Eur Respir J (2006) 7.00
Price of adaptation--allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med (1997) 6.79
Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA (1997) 6.12
The effect of acute renal failure on mortality. A cohort analysis. JAMA (1996) 6.09
Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax (2003) 4.81
The Burlington randomized trial of the nurse practitioner: health outcomes of patients. Ann Intern Med (1974) 4.37
Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med (2000) 4.33
Importance of functional measures in predicting mortality among older hospitalized patients. JAMA (1998) 4.33
Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly. Am J Epidemiol (1993) 4.13
Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J (2006) 3.89
A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med (2001) 3.86
Problems in the "evidence" of "evidence-based medicine". Am J Med (1997) 3.85
Nurse practitioners in primary care. I. The McMaster University educational program. Can Med Assoc J (1973) 3.65
An empirical demonstration of Berkson's bias. J Chronic Dis (1978) 3.48
Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA (1997) 3.47
Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. Am J Respir Crit Care Med (2000) 3.43
Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest (1999) 3.28
Problems of comorbidity in mortality after prostatectomy. JAMA (1992) 3.27
Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med (2000) 3.24
Applying results of randomised trials to clinical practice: impact of losses before randomisation. Br Med J (Clin Res Ed) (1984) 3.24
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women. Contraception (1996) 3.23
The International Health Program: the fifteen-year experience with Yale University's Internal Medicine Residency Program. Am J Trop Med Hyg (1999) 3.23
Stratified randomization for clinical trials. J Clin Epidemiol (1999) 3.16
Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest (2000) 3.12
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J (2002) 3.06
A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med (1993) 3.01
Patterns of preventive practice in New Brunswick. Can Med Assoc J (1985) 2.90
Quality-of-care appraisal in primary care: a quantitative method. Ann Intern Med (1975) 2.87
Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol (1997) 2.84
Bronchodilators and acute cardiac death. Am J Respir Crit Care Med (1996) 2.80
Forces contributing to the conformational stability of proteins. FASEB J (1996) 2.76
Sex differences in mortality after myocardial infarction. Is there evidence for an increased risk for women? Circulation (1995) 2.76
Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc Natl Acad Sci U S A (1999) 2.76
The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med (1998) 2.73
Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam Consultation on Meta-Analysis. J Clin Epidemiol (1995) 2.73
Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J (2000) 2.71
Methodological issues in therapeutic trials of COPD. Eur Respir J (2008) 2.69
Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax (2005) 2.69
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med (1992) 2.62
A dynamic population model of disease progression in COPD. Eur Respir J (2005) 2.59
Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J (2009) 2.52
Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1997) 2.52
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
A predictive index for functional decline in hospitalized elderly medical patients. J Gen Intern Med (1993) 2.34
Mortality among street youth. Lancet (1998) 2.32
Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med (1997) 2.28
First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception (1997) 2.27
Control of asthma in Canada: failure to achieve guideline targets. Can Respir J (2001) 2.26
The nurse practitioner revisited. Slow death of a good idea. N Engl J Med (1984) 2.24
Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers. BMJ (1996) 2.20
Complexity and contradiction in clinical trial research. Am J Med (1987) 2.17
Gender differences in smoking cessation after 3 years in the Lung Health Study. Am J Public Health (1995) 2.16
Clinical interpretation of airway response to a bronchodilator. Epidemiologic considerations. Am Rev Respir Dis (1988) 2.15
Evaluating the efficacy of cancer screening: clinical distinctions and case-control studies. J Clin Epidemiol (1995) 2.13
Adult cancer prevention in primary care: contrasts among primary care practice settings in Québec. Am J Public Health (1983) 2.11
Methodologic standards and contradictory results in case-control research. Am J Med (1979) 2.09
Measures of effect based on the sufficient causes model. 1. Risks and rates of disease associated with a single causative agent. Epidemiology (1993) 2.06
Sustained-release bupropion for pharmacologic relapse prevention after smoking cessation. a randomized, controlled trial. Ann Intern Med (2001) 2.06
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med (1997) 2.04
A collection of 56 topics with contradictory results in case-control research. Int J Epidemiol (1988) 2.02
A new clinical prognostic staging system for acute pancreatitis. Am J Med (1993) 2.02
The lymphoid transcription factor LyF-1 is encoded by specific, alternatively spliced mRNAs derived from the Ikaros gene. Mol Cell Biol (1994) 1.99
Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis (1991) 1.99
An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum (2005) 1.96
First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax (1998) 1.90
Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis (1973) 1.89
Present and future costs of COPD in Iceland and Norway: results from the BOLD study. Eur Respir J (2009) 1.89
Absence of relationship between tuberculin reactivity and atopy in BCG vaccinated young adults. Thorax (2000) 1.88
Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG (2007) 1.85
Chronic Obstructive Pulmonary Disease Early Intervention Trial (Lung Health Study). Baseline characteristics of randomized participants. Chest (1993) 1.85
Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer (1999) 1.85
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Double standards, scientific methods, and epidemiologic research. N Engl J Med (1982) 1.81